Loading…

DeltaNp63 expression in pancreas and pancreatic neoplasia

DeltaNp63 (DNp63) has become widely used, in particular, for distinguishing invasive carcinomas from noninvasive ducts by highlighting the myoepithelial or basal cells in the breast and prostate, respectively. It is not known whether this marker may have any application in another exocrine organ, th...

Full description

Saved in:
Bibliographic Details
Published in:Modern pathology 2005-09, Vol.18 (9), p.1193-1198
Main Authors: Basturk, Olca, Khanani, Fayyaz, Sarkar, Fazlul, Levi, Edi, Cheng, Jeanette D, Adsay, N Volkan
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c486t-93c2b0faa918e4952578a6bc0ca13609e614a65cac05c2461c87fe119c5a0d483
cites cdi_FETCH-LOGICAL-c486t-93c2b0faa918e4952578a6bc0ca13609e614a65cac05c2461c87fe119c5a0d483
container_end_page 1198
container_issue 9
container_start_page 1193
container_title Modern pathology
container_volume 18
creator Basturk, Olca
Khanani, Fayyaz
Sarkar, Fazlul
Levi, Edi
Cheng, Jeanette D
Adsay, N Volkan
description DeltaNp63 (DNp63) has become widely used, in particular, for distinguishing invasive carcinomas from noninvasive ducts by highlighting the myoepithelial or basal cells in the breast and prostate, respectively. It is not known whether this marker may have any application in another exocrine organ, the pancreas. As the ductal and intraductal proliferations of this organ become better characterized, the need for markers to distinguish among these processes increases. We investigated immunohistochemical expression of DNP63 in 105 cases. A total of 25 cases were non-neoplastic pancreata, 25 were pancreatic intraepithelial neoplasia (PanIN) of various grades, and 50 were examples of pancreatic ductal adenocarcinoma. Sections of non-neoplastic pancreata included various types of non-neoplastic processes such as squamous/transitional metaplasia (five cases), which can be mistaken for high-grade PanINs, as well as various degrees of reactive ductal atypia and incidental microcysts with attenuated lining (five cases). No DNp63 expression was noted in normal pancreatic ducts. On the other hand, all five foci of squamous/transitional metaplasia were strongly and uniformly positive for this marker. DNp63 labeling was also noted in those incidental microcysts lined by attenuated cells, seen amidst normal pancreatic lobules. All PanINs were negative. Among invasive carcinomas, DNp63 expression was detected only in areas of squamous differentiation and was completely absent in ordinary ductal areas. Based on this observation, five additional cases of adenosquamous/squamous carcinoma was retrieved and stained, and the squamous components of all of these were also positive. In conclusion, (I) DNp63 is a reliable marker of squamous differentiation in the pancreas. It is valuable in distinguishing squamous/transitional metaplasia from PanINs, a distinction of importance for both researchers and diagnosticians. Among invasive carcinomas, it seems to be entirely specific for areas of squamous differentiation. (II) Those incidental microcysts seen in acinar lobules and lined by attenuated cells are also positive for DNp63, which suggests that they may be metaplastic in nature, and that they do not represent neoplastic cells. (III) Unlike the ducts of other exocrine organs, breast and prostate, there are no DNp63-expressing cells in the normal pancreatic ducts, and therefore, this marker cannot be used in distinguishing invasive carcinomas from the non-invasive ducts. (IV) No p63
doi_str_mv 10.1038/modpathol.3800401
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68500527</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0893395222045574</els_id><sourcerecordid>969913611</sourcerecordid><originalsourceid>FETCH-LOGICAL-c486t-93c2b0faa918e4952578a6bc0ca13609e614a65cac05c2461c87fe119c5a0d483</originalsourceid><addsrcrecordid>eNp9kEFP3DAUhK0K1N3S_gAOoKiH3gLPdux1xKmiLSAhuLRn663zFoyyTrATVP49XmVhJQ6cLGtmPo-HsUMOJxykOV13TY_DfdeeSANQAf_E5lxJKEEYtcfmYGpZylqJGfuS0gMAr5QRn9mMq3qhDa_mrP5F7YA3vZYF_e8jpeS7UPhQ9BhcJEwFhub1MnhXBOr6FpPHr2x_hW2ib9vzgP378_vv-WV5fXtxdf7zunSV0UNZSyeWsEKsuaEqd1ELg3rpwCGXGmrSvEKtHDpQTlSaO7NYEee1UwhNZeQB-zFx-9g9jpQGu_bJUdtirjImq40CUGKRjd_fGR-6MYbczQrB85dBbWh8MrnYpRRpZfvo1xifLQe7GdW-jWq3o-bM8RY8LtfU7BLbFbNBTIaUpXBHcffyR9SjKRRwGCO9UXf62aRTHvfJZ2hynoKjxkdyg206_wH9BTzRorU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>221159058</pqid></control><display><type>article</type><title>DeltaNp63 expression in pancreas and pancreatic neoplasia</title><source>Nature</source><creator>Basturk, Olca ; Khanani, Fayyaz ; Sarkar, Fazlul ; Levi, Edi ; Cheng, Jeanette D ; Adsay, N Volkan</creator><creatorcontrib>Basturk, Olca ; Khanani, Fayyaz ; Sarkar, Fazlul ; Levi, Edi ; Cheng, Jeanette D ; Adsay, N Volkan</creatorcontrib><description>DeltaNp63 (DNp63) has become widely used, in particular, for distinguishing invasive carcinomas from noninvasive ducts by highlighting the myoepithelial or basal cells in the breast and prostate, respectively. It is not known whether this marker may have any application in another exocrine organ, the pancreas. As the ductal and intraductal proliferations of this organ become better characterized, the need for markers to distinguish among these processes increases. We investigated immunohistochemical expression of DNP63 in 105 cases. A total of 25 cases were non-neoplastic pancreata, 25 were pancreatic intraepithelial neoplasia (PanIN) of various grades, and 50 were examples of pancreatic ductal adenocarcinoma. Sections of non-neoplastic pancreata included various types of non-neoplastic processes such as squamous/transitional metaplasia (five cases), which can be mistaken for high-grade PanINs, as well as various degrees of reactive ductal atypia and incidental microcysts with attenuated lining (five cases). No DNp63 expression was noted in normal pancreatic ducts. On the other hand, all five foci of squamous/transitional metaplasia were strongly and uniformly positive for this marker. DNp63 labeling was also noted in those incidental microcysts lined by attenuated cells, seen amidst normal pancreatic lobules. All PanINs were negative. Among invasive carcinomas, DNp63 expression was detected only in areas of squamous differentiation and was completely absent in ordinary ductal areas. Based on this observation, five additional cases of adenosquamous/squamous carcinoma was retrieved and stained, and the squamous components of all of these were also positive. In conclusion, (I) DNp63 is a reliable marker of squamous differentiation in the pancreas. It is valuable in distinguishing squamous/transitional metaplasia from PanINs, a distinction of importance for both researchers and diagnosticians. Among invasive carcinomas, it seems to be entirely specific for areas of squamous differentiation. (II) Those incidental microcysts seen in acinar lobules and lined by attenuated cells are also positive for DNp63, which suggests that they may be metaplastic in nature, and that they do not represent neoplastic cells. (III) Unlike the ducts of other exocrine organs, breast and prostate, there are no DNp63-expressing cells in the normal pancreatic ducts, and therefore, this marker cannot be used in distinguishing invasive carcinomas from the non-invasive ducts. (IV) No p63-expressing ‘stem' cells are present in the pancreas.</description><identifier>ISSN: 0893-3952</identifier><identifier>EISSN: 1530-0285</identifier><identifier>DOI: 10.1038/modpathol.3800401</identifier><identifier>PMID: 15976814</identifier><identifier>CODEN: MODPEO</identifier><language>eng</language><publisher>New York: Elsevier Inc</publisher><subject>Adenocarcinoma - metabolism ; Adenocarcinoma - pathology ; Biomarkers, Tumor - analysis ; Cancer ; Carcinoma in Situ - metabolism ; Carcinoma in Situ - pathology ; Carcinoma, Pancreatic Ductal - metabolism ; Carcinoma, Pancreatic Ductal - pathology ; Cell cycle ; Cyst ; DNA-Binding Proteins ; Gene amplification ; Genes, Tumor Suppressor ; Humans ; Immunohistochemistry ; invasive ductal adenocarcinoma ; Laboratory Medicine ; Medicine ; Medicine &amp; Public Health ; metaplasia ; original-article ; p63 ; Pancreas ; Pancreatic Ducts - metabolism ; Pancreatic Ducts - pathology ; Pancreatic Neoplasms - metabolism ; Pancreatic Neoplasms - pathology ; PanIN ; Pathology ; Phosphoproteins - biosynthesis ; Prostate ; Trans-Activators - biosynthesis ; Transcription Factors ; Tumor Suppressor Proteins ; Tumors</subject><ispartof>Modern pathology, 2005-09, Vol.18 (9), p.1193-1198</ispartof><rights>2005 United States &amp; Canadian Academy of Pathology</rights><rights>United States and Canadian Academy of Pathology, Inc. 2005</rights><rights>Copyright Nature Publishing Group Sep 2005</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c486t-93c2b0faa918e4952578a6bc0ca13609e614a65cac05c2461c87fe119c5a0d483</citedby><cites>FETCH-LOGICAL-c486t-93c2b0faa918e4952578a6bc0ca13609e614a65cac05c2461c87fe119c5a0d483</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,2727,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15976814$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Basturk, Olca</creatorcontrib><creatorcontrib>Khanani, Fayyaz</creatorcontrib><creatorcontrib>Sarkar, Fazlul</creatorcontrib><creatorcontrib>Levi, Edi</creatorcontrib><creatorcontrib>Cheng, Jeanette D</creatorcontrib><creatorcontrib>Adsay, N Volkan</creatorcontrib><title>DeltaNp63 expression in pancreas and pancreatic neoplasia</title><title>Modern pathology</title><addtitle>Mod Pathol</addtitle><addtitle>Mod Pathol</addtitle><description>DeltaNp63 (DNp63) has become widely used, in particular, for distinguishing invasive carcinomas from noninvasive ducts by highlighting the myoepithelial or basal cells in the breast and prostate, respectively. It is not known whether this marker may have any application in another exocrine organ, the pancreas. As the ductal and intraductal proliferations of this organ become better characterized, the need for markers to distinguish among these processes increases. We investigated immunohistochemical expression of DNP63 in 105 cases. A total of 25 cases were non-neoplastic pancreata, 25 were pancreatic intraepithelial neoplasia (PanIN) of various grades, and 50 were examples of pancreatic ductal adenocarcinoma. Sections of non-neoplastic pancreata included various types of non-neoplastic processes such as squamous/transitional metaplasia (five cases), which can be mistaken for high-grade PanINs, as well as various degrees of reactive ductal atypia and incidental microcysts with attenuated lining (five cases). No DNp63 expression was noted in normal pancreatic ducts. On the other hand, all five foci of squamous/transitional metaplasia were strongly and uniformly positive for this marker. DNp63 labeling was also noted in those incidental microcysts lined by attenuated cells, seen amidst normal pancreatic lobules. All PanINs were negative. Among invasive carcinomas, DNp63 expression was detected only in areas of squamous differentiation and was completely absent in ordinary ductal areas. Based on this observation, five additional cases of adenosquamous/squamous carcinoma was retrieved and stained, and the squamous components of all of these were also positive. In conclusion, (I) DNp63 is a reliable marker of squamous differentiation in the pancreas. It is valuable in distinguishing squamous/transitional metaplasia from PanINs, a distinction of importance for both researchers and diagnosticians. Among invasive carcinomas, it seems to be entirely specific for areas of squamous differentiation. (II) Those incidental microcysts seen in acinar lobules and lined by attenuated cells are also positive for DNp63, which suggests that they may be metaplastic in nature, and that they do not represent neoplastic cells. (III) Unlike the ducts of other exocrine organs, breast and prostate, there are no DNp63-expressing cells in the normal pancreatic ducts, and therefore, this marker cannot be used in distinguishing invasive carcinomas from the non-invasive ducts. (IV) No p63-expressing ‘stem' cells are present in the pancreas.</description><subject>Adenocarcinoma - metabolism</subject><subject>Adenocarcinoma - pathology</subject><subject>Biomarkers, Tumor - analysis</subject><subject>Cancer</subject><subject>Carcinoma in Situ - metabolism</subject><subject>Carcinoma in Situ - pathology</subject><subject>Carcinoma, Pancreatic Ductal - metabolism</subject><subject>Carcinoma, Pancreatic Ductal - pathology</subject><subject>Cell cycle</subject><subject>Cyst</subject><subject>DNA-Binding Proteins</subject><subject>Gene amplification</subject><subject>Genes, Tumor Suppressor</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>invasive ductal adenocarcinoma</subject><subject>Laboratory Medicine</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>metaplasia</subject><subject>original-article</subject><subject>p63</subject><subject>Pancreas</subject><subject>Pancreatic Ducts - metabolism</subject><subject>Pancreatic Ducts - pathology</subject><subject>Pancreatic Neoplasms - metabolism</subject><subject>Pancreatic Neoplasms - pathology</subject><subject>PanIN</subject><subject>Pathology</subject><subject>Phosphoproteins - biosynthesis</subject><subject>Prostate</subject><subject>Trans-Activators - biosynthesis</subject><subject>Transcription Factors</subject><subject>Tumor Suppressor Proteins</subject><subject>Tumors</subject><issn>0893-3952</issn><issn>1530-0285</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNp9kEFP3DAUhK0K1N3S_gAOoKiH3gLPdux1xKmiLSAhuLRn663zFoyyTrATVP49XmVhJQ6cLGtmPo-HsUMOJxykOV13TY_DfdeeSANQAf_E5lxJKEEYtcfmYGpZylqJGfuS0gMAr5QRn9mMq3qhDa_mrP5F7YA3vZYF_e8jpeS7UPhQ9BhcJEwFhub1MnhXBOr6FpPHr2x_hW2ib9vzgP378_vv-WV5fXtxdf7zunSV0UNZSyeWsEKsuaEqd1ELg3rpwCGXGmrSvEKtHDpQTlSaO7NYEee1UwhNZeQB-zFx-9g9jpQGu_bJUdtirjImq40CUGKRjd_fGR-6MYbczQrB85dBbWh8MrnYpRRpZfvo1xifLQe7GdW-jWq3o-bM8RY8LtfU7BLbFbNBTIaUpXBHcffyR9SjKRRwGCO9UXf62aRTHvfJZ2hynoKjxkdyg206_wH9BTzRorU</recordid><startdate>20050901</startdate><enddate>20050901</enddate><creator>Basturk, Olca</creator><creator>Khanani, Fayyaz</creator><creator>Sarkar, Fazlul</creator><creator>Levi, Edi</creator><creator>Cheng, Jeanette D</creator><creator>Adsay, N Volkan</creator><general>Elsevier Inc</general><general>Nature Publishing Group US</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20050901</creationdate><title>DeltaNp63 expression in pancreas and pancreatic neoplasia</title><author>Basturk, Olca ; Khanani, Fayyaz ; Sarkar, Fazlul ; Levi, Edi ; Cheng, Jeanette D ; Adsay, N Volkan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c486t-93c2b0faa918e4952578a6bc0ca13609e614a65cac05c2461c87fe119c5a0d483</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adenocarcinoma - metabolism</topic><topic>Adenocarcinoma - pathology</topic><topic>Biomarkers, Tumor - analysis</topic><topic>Cancer</topic><topic>Carcinoma in Situ - metabolism</topic><topic>Carcinoma in Situ - pathology</topic><topic>Carcinoma, Pancreatic Ductal - metabolism</topic><topic>Carcinoma, Pancreatic Ductal - pathology</topic><topic>Cell cycle</topic><topic>Cyst</topic><topic>DNA-Binding Proteins</topic><topic>Gene amplification</topic><topic>Genes, Tumor Suppressor</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>invasive ductal adenocarcinoma</topic><topic>Laboratory Medicine</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>metaplasia</topic><topic>original-article</topic><topic>p63</topic><topic>Pancreas</topic><topic>Pancreatic Ducts - metabolism</topic><topic>Pancreatic Ducts - pathology</topic><topic>Pancreatic Neoplasms - metabolism</topic><topic>Pancreatic Neoplasms - pathology</topic><topic>PanIN</topic><topic>Pathology</topic><topic>Phosphoproteins - biosynthesis</topic><topic>Prostate</topic><topic>Trans-Activators - biosynthesis</topic><topic>Transcription Factors</topic><topic>Tumor Suppressor Proteins</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Basturk, Olca</creatorcontrib><creatorcontrib>Khanani, Fayyaz</creatorcontrib><creatorcontrib>Sarkar, Fazlul</creatorcontrib><creatorcontrib>Levi, Edi</creatorcontrib><creatorcontrib>Cheng, Jeanette D</creatorcontrib><creatorcontrib>Adsay, N Volkan</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Modern pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Basturk, Olca</au><au>Khanani, Fayyaz</au><au>Sarkar, Fazlul</au><au>Levi, Edi</au><au>Cheng, Jeanette D</au><au>Adsay, N Volkan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>DeltaNp63 expression in pancreas and pancreatic neoplasia</atitle><jtitle>Modern pathology</jtitle><stitle>Mod Pathol</stitle><addtitle>Mod Pathol</addtitle><date>2005-09-01</date><risdate>2005</risdate><volume>18</volume><issue>9</issue><spage>1193</spage><epage>1198</epage><pages>1193-1198</pages><issn>0893-3952</issn><eissn>1530-0285</eissn><coden>MODPEO</coden><abstract>DeltaNp63 (DNp63) has become widely used, in particular, for distinguishing invasive carcinomas from noninvasive ducts by highlighting the myoepithelial or basal cells in the breast and prostate, respectively. It is not known whether this marker may have any application in another exocrine organ, the pancreas. As the ductal and intraductal proliferations of this organ become better characterized, the need for markers to distinguish among these processes increases. We investigated immunohistochemical expression of DNP63 in 105 cases. A total of 25 cases were non-neoplastic pancreata, 25 were pancreatic intraepithelial neoplasia (PanIN) of various grades, and 50 were examples of pancreatic ductal adenocarcinoma. Sections of non-neoplastic pancreata included various types of non-neoplastic processes such as squamous/transitional metaplasia (five cases), which can be mistaken for high-grade PanINs, as well as various degrees of reactive ductal atypia and incidental microcysts with attenuated lining (five cases). No DNp63 expression was noted in normal pancreatic ducts. On the other hand, all five foci of squamous/transitional metaplasia were strongly and uniformly positive for this marker. DNp63 labeling was also noted in those incidental microcysts lined by attenuated cells, seen amidst normal pancreatic lobules. All PanINs were negative. Among invasive carcinomas, DNp63 expression was detected only in areas of squamous differentiation and was completely absent in ordinary ductal areas. Based on this observation, five additional cases of adenosquamous/squamous carcinoma was retrieved and stained, and the squamous components of all of these were also positive. In conclusion, (I) DNp63 is a reliable marker of squamous differentiation in the pancreas. It is valuable in distinguishing squamous/transitional metaplasia from PanINs, a distinction of importance for both researchers and diagnosticians. Among invasive carcinomas, it seems to be entirely specific for areas of squamous differentiation. (II) Those incidental microcysts seen in acinar lobules and lined by attenuated cells are also positive for DNp63, which suggests that they may be metaplastic in nature, and that they do not represent neoplastic cells. (III) Unlike the ducts of other exocrine organs, breast and prostate, there are no DNp63-expressing cells in the normal pancreatic ducts, and therefore, this marker cannot be used in distinguishing invasive carcinomas from the non-invasive ducts. (IV) No p63-expressing ‘stem' cells are present in the pancreas.</abstract><cop>New York</cop><pub>Elsevier Inc</pub><pmid>15976814</pmid><doi>10.1038/modpathol.3800401</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0893-3952
ispartof Modern pathology, 2005-09, Vol.18 (9), p.1193-1198
issn 0893-3952
1530-0285
language eng
recordid cdi_proquest_miscellaneous_68500527
source Nature
subjects Adenocarcinoma - metabolism
Adenocarcinoma - pathology
Biomarkers, Tumor - analysis
Cancer
Carcinoma in Situ - metabolism
Carcinoma in Situ - pathology
Carcinoma, Pancreatic Ductal - metabolism
Carcinoma, Pancreatic Ductal - pathology
Cell cycle
Cyst
DNA-Binding Proteins
Gene amplification
Genes, Tumor Suppressor
Humans
Immunohistochemistry
invasive ductal adenocarcinoma
Laboratory Medicine
Medicine
Medicine & Public Health
metaplasia
original-article
p63
Pancreas
Pancreatic Ducts - metabolism
Pancreatic Ducts - pathology
Pancreatic Neoplasms - metabolism
Pancreatic Neoplasms - pathology
PanIN
Pathology
Phosphoproteins - biosynthesis
Prostate
Trans-Activators - biosynthesis
Transcription Factors
Tumor Suppressor Proteins
Tumors
title DeltaNp63 expression in pancreas and pancreatic neoplasia
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T07%3A22%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=DeltaNp63%20expression%20in%20pancreas%20and%20pancreatic%20neoplasia&rft.jtitle=Modern%20pathology&rft.au=Basturk,%20Olca&rft.date=2005-09-01&rft.volume=18&rft.issue=9&rft.spage=1193&rft.epage=1198&rft.pages=1193-1198&rft.issn=0893-3952&rft.eissn=1530-0285&rft.coden=MODPEO&rft_id=info:doi/10.1038/modpathol.3800401&rft_dat=%3Cproquest_cross%3E969913611%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c486t-93c2b0faa918e4952578a6bc0ca13609e614a65cac05c2461c87fe119c5a0d483%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=221159058&rft_id=info:pmid/15976814&rfr_iscdi=true